Barclays PLC boosted its stake in Sally Beauty Holdings, Inc. (NYSE:SBH - Free Report) by 36.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 212,159 shares of the specialty retailer's stock after buying an additional 56,879 shares during the quarter. Barclays PLC owned approximately 0.21% of Sally Beauty worth $2,878,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of SBH. Quarry LP grew its holdings in shares of Sally Beauty by 369.3% during the third quarter. Quarry LP now owns 2,980 shares of the specialty retailer's stock worth $40,000 after buying an additional 2,345 shares in the last quarter. Point72 DIFC Ltd purchased a new stake in Sally Beauty during the 3rd quarter valued at about $64,000. Quest Partners LLC raised its holdings in Sally Beauty by 16,095.6% in the 2nd quarter. Quest Partners LLC now owns 7,288 shares of the specialty retailer's stock valued at $78,000 after acquiring an additional 7,243 shares during the last quarter. nVerses Capital LLC purchased a new position in Sally Beauty in the 3rd quarter worth approximately $94,000. Finally, Algert Global LLC acquired a new position in shares of Sally Beauty during the 2nd quarter worth approximately $113,000.
Insider Activity at Sally Beauty
In related news, CAO Kim Mcintosh sold 4,300 shares of Sally Beauty stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $14.53, for a total value of $62,479.00. Following the completion of the transaction, the chief accounting officer now owns 16,685 shares in the company, valued at $242,433.05. The trade was a 20.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Scott C. Sherman sold 13,500 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $14.49, for a total transaction of $195,615.00. Following the completion of the sale, the insider now directly owns 42,431 shares in the company, valued at approximately $614,825.19. This represents a 24.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.56% of the stock is currently owned by company insiders.
Sally Beauty Trading Down 1.1 %
NYSE:SBH traded down $0.12 on Wednesday, reaching $11.25. 717,163 shares of the company's stock were exchanged, compared to its average volume of 1,440,368. The business has a fifty day moving average of $12.91 and a 200-day moving average of $12.21. The company has a quick ratio of 0.45, a current ratio of 2.20 and a debt-to-equity ratio of 1.56. Sally Beauty Holdings, Inc. has a 52-week low of $9.06 and a 52-week high of $14.79. The firm has a market capitalization of $1.15 billion, a price-to-earnings ratio of 7.81 and a beta of 1.51.
Sally Beauty (NYSE:SBH - Get Free Report) last released its earnings results on Thursday, November 14th. The specialty retailer reported $0.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The company had revenue of $935.00 million for the quarter, compared to analyst estimates of $935.88 million. Sally Beauty had a net margin of 4.13% and a return on equity of 31.37%. The firm's quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.42 EPS. As a group, analysts expect that Sally Beauty Holdings, Inc. will post 1.85 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the company. DA Davidson increased their price target on Sally Beauty from $12.00 to $13.00 and gave the company a "neutral" rating in a report on Friday, November 15th. Morgan Stanley raised their target price on Sally Beauty from $8.00 to $12.00 and gave the stock an "underweight" rating in a research note on Friday, November 15th. TD Cowen raised shares of Sally Beauty from a "hold" rating to a "buy" rating and boosted their price target for the company from $14.00 to $16.00 in a research report on Monday, November 25th. Raymond James raised shares of Sally Beauty from an "underperform" rating to a "market perform" rating in a research note on Friday, November 15th. Finally, StockNews.com upgraded shares of Sally Beauty from a "hold" rating to a "buy" rating in a report on Saturday, November 23rd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $13.50.
Read Our Latest Report on Sally Beauty
Sally Beauty Profile
(
Free Report)
Sally Beauty Holdings, Inc operates as a specialty retailer and distributor of professional beauty supplies. The company operates through two segments, Sally Beauty Supply and Beauty Systems Group. The Sally Beauty Supply segment offers beauty products, including hair color and care products, skin and nail care products, styling tools, and other beauty products for retail customers, salons, and salon professionals.
Featured Articles
Before you consider Sally Beauty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sally Beauty wasn't on the list.
While Sally Beauty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.